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ABSTRACT
Objective To compare the quality and accuracy of manual
office blood pressure and automated office blood
pressure using the awake ambulatory blood pressure as a
gold standard.
DesignMulti-site cluster randomised controlled trial.
Setting Primary care practices in five cities in eastern
Canada.
Participants 555 patients with systolic hypertension and
no serious comorbidities under the care of 88 primary
care physicians in 67 practices in the community.
Interventions Practices were randomly allocated to either
ongoing use of manual office blood pressure (control
group) or automated office blood pressure (intervention
group) using the BpTRU device. The last routine manual
office blood pressure (mm Hg) was obtained from each
patient’s medical record before enrolment. Office blood
pressure readings were compared before and after
enrolment in the intervention and control groups; all
readings were also compared with the awake ambulatory
blood pressure.
Main outcome measure Difference in systolic blood
pressure between awake ambulatory blood pressure
minus automated office blood pressure and awake
ambulatory blood pressure minus manual office blood
pressure.
Results Cluster randomisation allocated 31 practices (252
patients) tomanual office blood pressure and 36 practices
(303 patients) to automated office blood pressure
measurement. The most recent routine manual office
blood pressure (149.5 (SD 10.8)/81.4 (8.3)) was higher
than automated office blood pressure (135.6 (17.3)/77.7
(10.9)) (P<0.001). In the control group, routine manual
office blood pressure before enrolment (149.9 (10.7)/81.8
(8.5)) was reduced to 141.4 (14.6)/80.2 (9.5) after
enrolment (P<0.001/P=0.01), but the reduction in the
intervention group frommanual office to automated office
bloodpressurewas significantly greater (P<0.001/P=0.02).
On the first study visit after enrolment, the estimatedmean
difference for the intervention group between the awake
ambulatory systolic/diastolic blood pressure and
automated office blood pressure (−2.3 (95% confidence
interval −0.31 to −4.3)/−3.3 (−2.7 to −4.4)) was less
(P=0.006/P=0.26) than the difference in the control group
between the awake ambulatory blood pressure and the
manual office blood pressure (−6.5 (−4.3 to −8.6)/−4.3
(−2.9 to −5.8)). Systolic/diastolic automated office blood
pressure showed a stronger (P<0.001) within group
correlation (r=0.34/r=0.56) with awake ambulatory blood
pressure after enrolment compared with manual office
blood pressure versus awake ambulatory blood pressure
before enrolment (r=0.10/r= 0.40); the mean difference in
r was 0.24 (0.12 to 0.36)/0.16 (0.07 to 0.25)). The
between group correlation comparing diastolic automated
office blood pressure and awake ambulatory blood
pressure (r=0.56) was stronger (P<0.001) than that for
manual office blood pressure versus awake ambulatory
blood pressure (r=0.30); themean difference in rwas 0.26
(0.09 to 0.41). Digit preference with readings ending in
zero was substantially reduced by use of automated office
blood pressure.
Conclusion In compliant, otherwise healthy, primary care
patients with systolic hypertension, introduction of
automated office blood pressure measurement into
routine primary care significantly reduced the white coat
response comparedwith the ongoing use ofmanual office
bloodpressuremeasurement. The quality and accuracy of
automated office blood pressure in relation to the awake
ambulatory blood pressure was also significantly better
when compared with manual office blood pressure.
Trial registration Clinical trials NCT 00214053.
INTRODUCTION
Despite intensive efforts to promote proper techniques
for the measurement of blood pressure, widespread
concern about the quality and accuracy of blood pres-
sure measurement in “real life” clinical settings
continues.1 2 Studies from routine clinical practice
often report imprecise and inconsistent manual office
blood pressure readings owing to poor measurement
technique, patient-physician interaction such as con-
versation during readings, and failure to minimise
patient related factors such as anxiety.3 4 Recent studies
suggest that an accurate office blood pressure reading
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requires at least 14 minutes, including a period of rest
before the first measurement.5 6 The likelihood of such
careful adherence to protocols for blood pressuremea-
surement in routine, community based, office practice
would seem to be low.
In recognising these concerns about manual office
blood pressure measurement, some experts in hyper-
tension have recently recommended a more limited
role for such readings. Proposals for improved assess-
ment of blood pressure status include greater reliance
on home and 24 hour ambulatory blood pressure
monitoring.78 Not only do out of office readings elimi-
nate increased readings associated with conventional
manual office blood pressure measurement (the white
coat response), they are also stronger predictors of
future cardiovascular events.9 10 Detection and elimina-
tion of the white coat response also reduces the number
of patients who receive unnecessary drug treatment.11
Although the evidence supporting greater use of
home and 24 hour ambulatory blood pressure moni-
toring is substantial, to consider abandoning office
blood pressure measurement because of the deficien-
cies associated with conventional manual office read-
ings is both premature and unwise. Recent advances in
the development of automated sphygmomanometers
provide a third option for accurate assessment of blood
pressure status: automated office blood pressure mea-
surement. The use of independently validated, fully
automated sphygmomanometers designed for profes-
sional use reduces or eliminates many of the factors
contributing to imprecise blood pressure readings in
routine clinical practice.12-14 Self measurement with
the patient resting alone in a quiet examining room
makes it possible to eliminate patient-observer inter-
action such as conversation, an important cause of
the white coat response.15 16 The absence of a health
professional during blood pressure measurement also
seems to reduce the anxiety that many patients experi-
ence during visits to their doctor.17 18
We designed the Conventional versus Automated
Measurement of Blood pressure in the Office
(CAMBO) trial to evaluate the effect of automated ver-
sus manual office blood pressure measurement on the
management of hypertensive patients in routine, com-
munity based, clinical practice over a two year period.
Patients with predominantly systolic hypertension
were eligible for the study, as the white coat response
is associated with a disproportionate increase in systo-
lic blood pressure.2 This report presents findings from
the first phase of CAMBO, examining whether auto-
mated office blood pressure can reduce the white coat
response and improve on the quality and accuracy of
manual office blood pressure by producing readings
that are similar to and more strongly correlated with
the awake ambulatory blood pressure.
METHODS
Study design
We invited community based family physicians in five
Canadian cities who were using manual office blood
pressure in their clinical practice to participate in the
study. Physicians’ practices (sites) consisted of either
one family physician or a group of two or three physi-
cians sharing the same office space. To reduce poten-
tial contamination, we used a cluster randomisation
design in which we randomised sites rather than indi-
vidual patients to either manual office blood pressure
with continuing use of manual sphygmomanometry
(control group) or management of the study patients
with automated office blood pressure (intervention
group) using the BpTRU device (BpTRU Medical
Devices, Coquitlam, BC, Canada). We stratified ran-
domisation tomanagement with automated ormanual
office blood pressuremeasurement by city tominimise
possible regional differences in blood pressure mea-
surement and management of hypertension arising
from any imbalance between the groups. We set a tar-
get of 10 patients for each site, with a minimum of five
patients. We allowed up to 15 patients for practices in
which two or three physicians at one site were rando-
mised as a single cluster.
Recruitment of patients
We considered patients with a hypertension code on
billing forms to be eligible for the study if they satisfied
the initial screening criteria, including age over
45 years, no serious coexisting illness limiting partici-
pation, no history of non-compliance, not treated for
diabetes mellitus, serum creatinine less than twice nor-
mal, and not using or intending to use home blood
pressure measurements. We required untreated
patients to have a systolic blood pressure of at least
160 mm Hg and diastolic blood pressure below
95 mm Hg on their most recent pre-study visit, as
recorded in their medical chart. Patients already
receiving antihypertensive treatment were eligible if
their systolic blood pressure was at least 140 mm Hg
and their diastolic pressure was below 90 mm Hg.
Potential participants were sent a letter from the office
of their family physician asking if they would be inter-
ested in participating in CAMBO. Patients who agreed
to attend for a baseline visit were seen by a study nurse,
who explained the details of the study and verified that
the patients satisfied all of the inclusion criteria. Eligi-
ble patients who agreed to participate then had 24 hour
ambulatory blood pressuremonitoring before the next
scheduled follow-up visit with their regular physician.
The last routinemanual office blood pressure recorded
on the visit immediately before entry into the studywas
documented. We developed an intensity score using
arbitrary units for each antihypertensive drug, to assess
the amount of antihypertensive drugs being taken by
each patient at baseline and during subsequent visits
(for example, 1 unit for hydrochlorothiazide=12.5 mg,
atenolol=25 mg, amlodipine=2.5 mg). We defined
excess alcohol consumption as 14 or more standard
alcoholic beverages a week for men and nine or more
beverages a week for women.
Blood pressure measurement
The BpTRU is a fully automated sphygmomanometer
that records blood pressure by the oscillometric
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method. It is designed to take an initial reading to ver-
ify that the cuff is properly positioned to obtain valid
readings. The observer then leaves the patient alone,
and five more readings are taken automatically at pre-
specified intervals. The display shows the mean of the
five readings, as well as individual measurements. A
rest period is not needed before the first reading. In
CAMBO, the BpTRU was set to take readings at two
minute intervals (from the start of one reading to the
start of the next one). Recent studies have noted similar
readings when taken at one or two minute intervals.19
We explained the operation of the device to the physi-
cians and their staff, emphasising the requirement that
the patient should be left alone during five readings.
We told physicians randomised to the manual office
blood pressure control group to continue recording
blood pressure as before. None of the physicians in
the study in either group was given any additional
instructions on proper blood pressure measurement
technique. We provided a data collection form for the
observers to document the blood pressure readings as
soon as they were obtained.
Twenty four hour ambulatory blood pressure mon-
itoring was recorded with a Spacelabs Model 90207
(Spacelabs Healthcare, Issaquah, WA, USA) unit.
This device has been validated for accuracy20; it has
been the most widely used recorder for ambulatory
blood pressure monitoring in clinical research studies.
Patients were instructed to engage in routine daily
activities during 24 hour ambulatory blood pressure
monitoring. The device was set to record blood pres-
sure at 15minute intervals between 0600 and 2200 and
at 30 minute intervals during the night.We then calcu-
lated the mean awake ambulatory blood pressure
according to the actual awake period as recorded in
each patient’s diary, where time asleep was noted.
Data analysis
We calculated descriptive statistics for variables of
interest. We report continuous variables as mean and
standard deviation and show differences between
mean values with confidence intervals. This analysis
focuses on baseline comparisons of blood pressure
readings between participants randomised to the two
study arms using manual office blood pressure, auto-
mated office blood pressure, and 24 hour ambulatory
blood pressure monitoring. We use Bland-Altman
scatter plots to show differences between blood pres-
sure measurements,21 which we evaluated by using
repeated measures analysis of variance models. The
models took into account the correlated nature of the
data and the potential data dependency associatedwith
the cluster design.
We assessed differences in coefficients of correlation
between comparisons of blood pressure readings by
using independent correlation coefficients for between
group comparisons and correlated coefficients for
within group comparisons.We used χ2 tests to evaluate
differences between groups in the proportion of
patients showing digit preference (rounding off blood
pressure readings to the nearest zero value). Applying
the method of Donner et al,22 the study was powered
for the primary outcomemeasure to detect a difference
of 5 mm Hg between groups (difference in awake
ambulatory systolic blood pressure minus manual
office blood pressure versus difference in awake ambu-
latory systolic blood pressure minus automated office
blood pressure), with 90% power at α=0.05, a hypothe-
sised intracluster correlation of 0.07, and a 20% attri-
tion rate. The resulting estimated sample size was 276
participants per group.We used SAS version 9.1 for all
analyses.
RESULTS
We recruited 572 patients from primary care practices
in four regions in central and eastern Canada: Belle-
ville (Ontario), Brantford (Ontario), Montreal (Que-
bec), and St John’s/Corner Brook (Newfoundland),
as shown in figure 1. We excluded 12 patients from
participation because fewer than five patients were
recruited from each of their physicians’ practices.
Five other patients declined to have 24 hour ambula-
tory blood pressuremonitoring after having signed the
consent form. The cluster randomisation process
allocated 303 patients to management of their hyper-
tension with automated office blood pressure (inter-
vention group) and 252 patients to ongoing manual
office blood pressure measurement (control group).
The intervention group consisted of 36 practices (52
physicians), compared with 31 practices (36 physi-
cians) in the control group. The imbalance in the num-
ber of patients in each group was partly due to more
sites with multiple physicians being randomised to
Control (MOBP) group
Physicians/clusters (n=36/31)
Patients (n=252)
Intervention (AOBP) group
Physicians/clusters (n=52/36)
Patients (n=303)
Physicians invited to participate (n=215)
Baseline ABPM assessment requested (n=572)
Physicians (clusters) agreed to participate (n=92 (71))
Consenting, eligible patients (n=609)
Physicians/clusters randomised (n=88/67)
Patients randomised (n=555)
Withdrew consent (n=2)
Fatal myocardial infarction (n=1)
Withdrew consent (n=4)
Analysed (n=249)Analysed (n=299)
Physicians declined to participate (n=123)
Patients who withdrew
consent/did not return (n=37)
Patients with incomplete ABPM (n=5)
<5 patients per physician (cluster) (n=12)
<5 patients per physician (cluster)
(n=4 physicians/clusters)
Fig 1 | Flow diagram showing recruitment of family physicians and patients into trial. ABPM=24
hour ambulatory blood pressure monitoring; AOBP=automated office blood pressure;
MOBP=manual office blood pressure
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automatedoffice bloodpressure. In addition, randomi-
sationwas stratified by the four regions (Brantford, Bel-
leville,Montreal, and St John’s/Corner Brook) and, by
chance, this resulted inmore sites being allocated to the
intervention group. After randomisation, four patients
in the intervention group and two patients in the con-
trol group withdrew consent before attending the first
within study office visit. Another patient in the control
group had a fatal myocardial infarction before his
return office visit.
No significant differences existed in the characteris-
tics of the patients randomised to the two groups
(table 1). Routine manual office blood pressure read-
ings taken during the visit immediately before enrol-
ment into the study and the mean awake ambulatory
blood pressure at baseline were similar in the two
groups (table 2).
With respect to the primary outcome measure, the
mean estimated difference between the mean awake
ambulatory systolic/diastolic blood pressure and the
automated office blood pressure in the intervention
group at the first office visit after enrolment was −2.3
(95% confidence interval −0.3 to −4.3)/−3.3 (−2.2 to
−4.4) (P=0.02/P<0.001). The corresponding difference
between the awake ambulatory blood pressure and
manual office blood pressure for the first post-enrol-
ment office visit in the control group was −6.5 (−4.3
to −8.6)/−4.3 (−2.9 to −5.8) (P<0.001/P<0.001)
(table 2). The mean estimated difference for systolic
manual office blood pressure (−6.5) was significantly
greater (P=0.006) than that for systolic automated
office blood pressure (−2.3). The difference for diasto-
lic manual office blood pressure was not significant
(P=0.26).
Both groups showed a fall in mean office blood pres-
sure between themost recently recorded pre-study rou-
tine office visit and the first visit to the physician after
enrolment in the study (table 2). Mean blood pressure
in the automated office blood pressure group was
reduced by 13.9 (11.8 to 16.1)/3.7 (2.5 to 4.8) mm Hg,
which was more (P<0.001/P=0.02) than for the manual
office blood pressure patients (8.5 (6.5 to 10.4)/1.6 (0.4
to 2.8) mm Hg). None of the patients changed anti-
hypertensive drug treatment between the last routine
office visit and the first visit to the office after the 24
hour ambulatory blood pressure monitoring.
Routine manual office systolic blood pressure read-
ings in both groups taken before participation in the
study correlated poorly with the mean awake ambula-
tory blood pressure (table 3). For patients in the inter-
vention group, the within group correlations between
awake ambulatory blood pressure and systolic/diasto-
lic automated office blood pressure at the first office
visit after enrolment in the study were significantly
higher than those for the ambulatory blood pressure
versus the last routine manual office blood pressure
before entry into the study (r=0.34 versus r=0.10
(95% confidence interval for change 0.12 to 0.36),
P<0.001/r=0.56 versus r=0.40 (0.07 to 0.25),
P<0.001). For the control group, we saw both positive
and negative changes in correlation coefficients
between the manual office systolic/diastolic blood
pressure readings and the awake ambulatory blood
pressure from before to after enrolment in the study
(r=0.04 versus r=0.22 (0.02 to 0.32), P=0.03/r=0.42 ver-
sus r=0.30 (0.0, –0.01 to 0.24), P=0.08). The between
group correlation between diastolic automated office
blood pressure and awake ambulatory blood pressure
(r=0.56) was stronger (P=<0.001) than that for manual
office blood pressure versus awake ambulatory blood
pressure (r=0.30); the mean difference in r was 0.26
(0.09 to 0.41).
We plotted the mean awake ambulatory and office
systolic blood pressure readings against the difference
between these readings by using the Bland-Altman
scatter plot format (fig 2). 21 Routine mean pre-entry
manual office blood pressure readings (top panels)
showed a marked positive bias in the intervention
group (16.3 (2 SD −14.4-46.9)) and control group
(14.9 (−17.5-47.3)), whereas the automated office
blood pressure readings (bottom left panel) showed
minimal bias (2.3 (−31.9-36.6)), reflecting less of a
white coat response. Manual office blood pressure
readings taken on the first office visit after enrolment
(bottom right panel) showed amoderate degree of bias
(6.5 (−27.6-40.5)), consistent with a partial fall in blood
pressure compared with routine manual office blood
pressure readings recorded before enrolment.
Digit preference, with manual office blood pressure
readings being rounded off to the nearest zero, was
common in both the automated and manual office
blood pressure groups at the last routine office visit
before enrolment. For automated office bloodpressure
patients, the number of individual readings that
showed digit preference for systolic/diastolic blood
pressure at this visit (n=183 (61%)/n=173 (58%)) was
substantially reduced (P<0.001) to n=43 (14%)/n=42
(14%) at the first study office visit when automated
office blood pressure readings were taken. In contrast,
digit preference in the control group with manual
office blood pressure readings at the last routine office
visit (n=128 (51%)/n=143 (57%)) was not significantly
different from manual office blood pressure readings
taken during the subsequent first study office visit
(n=107 (43%)/n=124 (50%)).
Table 1 | Characteristics of patients who completed baseline period and were randomised to
intervention group (automated office blood pressure) or usual care group (continued manual
office blood pressure) for management of hypertension. Values are numbers (percentages)
unless stated otherwise
Characteristic
Automated office blood
pressure (n=303)
Conventional manual office
blood pressure (n=252)
Male sex 107 (35) 103 (41)
Mean (range) age (years) 65 (45-90) 65 (46-84)
Mean (SD) duration of hypertension (years) 9.2 (8.9) 9.6 (10.4)
Not receiving antihypertensive treatment 13 (4) 12 (5)
Mean (SD) intensity of antihypertensive drug
treatment (units)
3.7 (2.3) 3.5 (2.2)
Cigarette smokers 39 (13) 37 (15)
Excess alcohol use 21 (7) 13 (5)
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All six automated office blood pressure readings
taken with the BpTRU device were recorded in 284
patients. The initial blood pressurewith the health pro-
fessionals still in the room (147 (SD 20)/82 (12) mm
Hg) was significantly (P<0.001) higher than all of the
other blood pressure readings and the mean auto-
mated office blood pressure (table 4).
DISCUSSION
These initial findings in primary care patients with sys-
tolic hypertension are important in that they provide
robust, internally and externally valid evidence to sup-
port the use of automated office blood pressure mea-
surement in routine office practice. Manual office
blood pressure readings taken before enrolment were
significantly higher than the awake ambulatory blood
pressure, which is considered to be a gold standard for
defining blood pressure status. The routine manual
office systolic blood pressure readings also correlated
poorly with the awake ambulatory blood pressure.
Replacement of manual office blood pressure mea-
surement with automated office blood pressure vir-
tually eliminated the difference between the routine
manual office blood pressure and the awake ambula-
tory blood pressure (white coat effect). Automated
office blood pressure readings also showed a stronger
correlation with the awake ambulatory blood pressure
than did manual readings.
A unique feature of theCAMBOtrial is the inclusion
of a control group of patients randomised to usual care
with manual office blood pressure measurements. In
CAMBO, the difference between the routine systolic/
diastolic manual and automated office blood pressure
was−13.9/−3.7mmHg.Not all of this difference could
be attributed to the intervention, as readings in the
manual office blood pressure control group also
decreased by −8.5/−1.6 mm Hg after enrolment com-
pared with before enrolment. The fall in blood pres-
sure in the control group was probably due to several
factors, including increased compliance with drug
treatment after enrolment on the part of some patients,
physicians and nurses reading blood pressure lower,
and regression to the mean. Although changes in pre-
scribed drugs were documented in the physicians’
notes, patients were not specifically asked about com-
pliance to avoid influencing their treatment. A change
in technique formanual office bloodpressuremeasure-
ment on the part of the medical staff seems less likely,
as readings taken on the first visit after enrolment were
not any more accurate than the routine manual office
blood pressure; digit preference was still present, and
manual office blood pressure readings still correlated
relatively poorly with the awake ambulatory blood
pressure.
By subtracting the decrease in blood pressure in the
control group from the decrease in the automated
office blood pressure group, we can obtain the net
reduction in blood pressure that can be attributed spe-
cifically to the automated office blood pressure inter-
vention: −5.4/−2.1 mm Hg, which is still of
considerable clinical importance. This value should
be considered a minimum reduction in view of the
likely changes in the patients’ compliance with drug
treatment and possible measurement bias based on
the fall in blood pressure in the control group.
A recent report by Godwin et al provides further
information on the effect that automated office blood
pressure measurement might have on the white coat
component of manual office blood pressure
measurements.23 In their study, 654 treated
Table 2 | Mean (SD) blood pressure (BP) taken in physicians’ office before and after enrolment into study and baseline mean awake ambulatory BP recorded
between two office visits for patients randomised to intervention (automated office BP) and control (manual office BP) groups, with estimated mean
differences (95% confidence interval) between BP readings
Measurement Automated office BP group (n=299) Conventional manual office BP group (n=249)
Last routine manual office BP (mm Hg) 149.5 (10.8)/81.4 (8.3) 149.9 (10.7)/81.8 (8.5)
Office BP (mm Hg) after enrolment 135.6 (17.3)/77.7 (10.9) 141.4 (14.6)/80.2 (9.5)
Difference from last routine office BP (mm Hg) −13.9 (−11.8 to −16.1)***/−3.7 (−2.5 to −4.8)*** −8.5 (−6.5 to −10.4)***/−1.6 (−0.4 to −2.8)**
Awake ambulatory BP (mm Hg) 133.2 (12.4)/74.4 (9.8) 135.0 (13.1)/75.9 (10.0)
Difference from last routine office BP (mm Hg) −16.3 (−14.5 to −18.1)***/−7.0 (−5.8 to 8.1)*** −14.9 (−12.9 to −17.0)***/−5.9 (−4.6 to 7.2)***
Difference from post-enrolment office BP (mm Hg) −2.3 (−0.31 to −4.3)*/−3.3 (−2.2 to −4.4)*** −6.5 (−4.3 to −8.6)***/−4.3 (−2.9 to 5.8)***
*P=0.02.
**P=0.01.
***P<0.001.
Table 3 | Coefficients of correlation between office systolic/diastolic blood pressure (BP) readings and mean awake
ambulatory BP
Measurements Automated office BP group Manual office BP group
Routine office BP before enrolment v awake ambulatory BP r=0.10/r=0.40 r=0.04/r=0.42
First office BP after enrolment v awake ambulatory BP r=0.34/r=0.56* r=0.22/r=0.30
Estimatedmeandifference (95%CI) in r frombefore to after
enrolment
0.24 (0.12 to 0.36)†/0.16 (0.07 to 0.25)† 0.18 (0.02 to 0.32)‡/−0.12 (−0.01 to 0.24)
*Estimated between group mean difference from post-enrolment manual office diastolic BP (r=0.30) was 0.26 (0.09 to 0.41); P<0.001.
†P<0.001.
‡P=0.03.
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hypertensive patients had automated office bloodpres-
sure and 24 hour ambulatory blood pressure monitor-
ingdone immediately after providingwritten informed
consent, leaving the patients no chance to increase
their adherence to antihypertensive treatment. Under
these circumstances, the routine manual office blood
pressure of 148.5/82.5 mm Hg was reduced to 139.2/
79.8 mm Hg when blood pressure recordings were
taken with the BpTRU device. The corresponding
mean awake ambulatory blood pressure was 140.9/
79.6 mm Hg. Both the patients in this study and those
in CAMBO were recruited from primary care prac-
tices in the community, and routine manual office
blood pressure readings before enrolmentwere similar
in the two studies.
Other populations have shown greater reductions in
blood pressure when readings were taken with the
BpTRU device. Routine manual office blood pressure
in 254 untreated patients referred for 24 hour ambula-
tory blood pressure monitoring was reduced from
149.7/89.3 mm Hg to 132.6/80.0 mm Hg when auto-
mated office blood pressure was recorded in an ambu-
latory blood pressure monitoring unit.24 The
corresponding awake ambulatory blood pressure was
135.3/81.0 mm Hg. The greater reduction in blood
pressure in these patientswas probably due to selection
of patients, whereby physicians referred patients with
suspected white coat hypertension for 24 hour ambu-
latory blood pressure monitoring. As these patients
were untreated and routine manual office blood
pressure readings were taken, little possibility exists
that a change in patients’ or physicians’ behaviour
could explain the lower automated office blood pres-
sure values.
The introduction of automated office blood pressure
into routine clinical practice could be thus expected to
decrease systolic blood pressure readings by at least
5 mm Hg and probably by 9 to 13 mmHg depending
on the population of patients.
Should manual office blood pressure measurement be
abandoned?
The mercury sphygmomanometer has been synon-
ymous with blood pressure measurement for more
than 100 years. Regardless of advances in alternative
techniques for recording blood pressure, mercury
seems destined to disappear from the workplace
because of environmental concerns. Mercury is pro-
hibited in at least two countries,25 and a recent report
from the European Union suggests that a more wide-
spread ban is imminent.26 The standard device for
measuring blood pressure thus needs to be replaced,
but the unknown factor is what comes next. Studies
on white coat hypertension have identified a subset of
about 25% of the hypertensive population who have
clinically important increases in blood pressure when
readings are taken in the treatment setting, especially
by physicians.27 Even automated devices such as the
BpTRU provoke a white coat response; readings are
similar to manual office blood pressure if the observer
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Fig 2 | Mean of office blood pressure (BP) and awake ambulatory BP readings plotted against difference between these
readings, using Bland-Altman format.21 Shows data for awake ambulatory BP versus routine manual office (MO) BP readings
before enrolment (top panels), AOBP readings after enrolment (bottom left panel), and MOBP readings after enrolment (bottom
right panel). Horizontal lines indicate two standard deviations around the mean difference. Values for estimated mean bias (2
SD) are shown
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remains present in the room when the reading is
taken.17
Studies comparing manual with automated office
blood pressure have clearly shown that the increase
in bloodpressure associatedwith conventionalmanual
officemeasurement can be eliminated if the three basic
tenets of automated office blood pressure are followed:
the patient rests alone in a quiet room, and multiple
readings are taken with a fully automated device.2
The simple presence of an observer seems to increase
blood pressure, as marked decreases in automated
office blood pressure are evident within two minutes
of the observer leaving the room, as seen in CAMBO
and in a previous study.17
The number of automated office blood pressure
readings needed for the mean value to be equivalent
to the awake ambulatory blood pressure depends on
whether the patient rests before the first reading is
taken.28 If current guidelines for manual office blood
pressure are followed and the patient is allowed to rest
for at least fiveminutes, only twoor three readingsmay
be needed. However, when five readings are taken at
one minute intervals with devices such as the BpTRU,
no antecedent period of rest is needed and mean read-
ings are still equivalent to the awake ambulatory blood
pressure.29 30 Also, readings obtained with the BpTRU
are similarwhen taken at one or twominute intervals.28
In countries such as Canada, physicians in primary
care practice generally use several examining rooms
for seeing patients. This arrangement is suitable for
automated andmanual office blood pressuremeasure-
ment, even when the manual readings are taken
according to guidelines with fiveminutes of rest before
the first blood pressure measurement. When physi-
cians have access to only one examining room, less
time is available for optimal recording of a patient’s
blood pressure. Under these circumstances, both auto-
matedoffice bloodpressure and apropermanual office
blood pressure are generally not feasible. An essential
feature of automated office blood pressure is the
requirement that the patient should be seated in a
quiet room for several minutes while readings are
being taken. If only one or two readings are recorded
without an antecedent period of rest, a white coat effect
would probably affect the bloodpressure value, as seen
with the first two readings taken using the BpTRU
device.17 The improved accuracy associatedwith auto-
mated office blood pressure is probably achieved by
having the patient resting alone and by the use of an
automated, validated device to take multiple, standar-
dised readings.
Automated office blood pressure recorders need to
be fully automated. In a recent study,30 the more
expensive BpTRUdevice was replacedwith validated,
home blood pressure recorders, which patients acti-
vated five times at one minute intervals while alone in
a quiet room. Mean blood pressure taken with the
patient activated, automated recorders was about
5 mmHg higher than automated office blood pressure
taken with the BpTRU, awake ambulatory blood pres-
sure, and home blood pressure. If simply getting a
patient to push a button every minute increases blood
pressure, then the fact that manual office blood pres-
sure readings in the presence of an observer are
increased by at least 5 mmHg is not surprising.
Manual blood pressure also very much depends on
the circumstances in which readings are taken. Pres-
sure is higherwhen taken by physicians than bynurses,
higher in treatment settings than in non-treatment set-
tings, and lowerwhen taken at home.31 32Manual office
blood pressure can be 15-18 mm Hg higher than the
awake ambulatory blood pressure if recorded in rou-
tine clinical practice.16 24 In contrast, automated office
blood pressure and awake ambulatory blood pressure
generally differ by less than 3mmHg, both in research
settings and in clinical practice, as seen in CAMBO.2
Manual blood pressure also decreases if a patient
moves from the physician’s office to a non-treatment
setting such as an ambulatory blood pressure monitor-
ing unit,32 whereas automated office blood pressure
does not fall.29
Limitations of study
The design of CAMBO is responsible for its major
strengths and weaknesses. Despite the difficulties
involved in doing a randomised controlled trial of
blood pressure measurement in routine clinical prac-
tice, we could show that replacement of manual with
automated office blood pressure could significantly
reduce thewhite coat response associatedwith conven-
tional office blood pressure measurement. By restrict-
ing the intervention solely to blood pressure
measurement, we can generalise findings to hyperten-
sion management in most primary care practices, tak-
ing into consideration the fact that the patients in
CAMBO were aged 45 and over, had predominantly
systolic hypertension, did not have diabetes, and were
free of any target organ damage. Further research is
needed before the results of CAMBO can be extra-
polated to other hypertensive populations.
CAMBO was designed to interfere as little as possi-
ble with routine management of patients. As a conse-
quence, we could not provide instructions on proper
technique for manual office blood pressure measure-
ment, which would almost certainly have improved
the quality of the readings. Moreover, research quality
manual readings are generally not seen in routine
Table 4 | Sequential mean (SD) blood pressure readings
taken every two minutes in 284 patients with BpTRU device
during first routine office visit after enrolment into study
Reading No Automated office blood pressure (mm Hg)
1 147 (20)/82 (12)*
2 140 (20)/79 (12)
3 136 (19)/78 (13)
4 134 (18)/77 (12)
5 132 (18)/76 (12)
6 133 (18)/77 (12)
Mean 2-6 136 (18)/78 (11)
*P<0.001 versus all subsequent readings.
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clinical practice. The mean automated office blood
pressure would also probably have been even lower
if physicians and their staff had been reminded not to
disturb patients during the automated office blood
pressure readings. The mean automated office blood
pressure inCAMBOwas higher than the awake ambu-
latory blood pressure, whereas in other studies auto-
mated office blood pressure was either the same as or
lower than the awake ambulatory blood pressure.2
Thus, improving the quality of both the automated
and manual office blood pressure readings might
have been possible if CAMBO had been designed
more as a research study, but the results would have
had less relevance to “real world” primary care prac-
tice.
Implications of CAMBO study
The CAMBO trial has important implications for the
diagnosis and treatment of hypertension. Existing
guidelines are almost exclusively based on morbidity
and mortality data related to “research quality” blood
pressure readings. However, the cut-off point of 140/
90 mm Hg for diagnosing and treating hypertension
was not derived from blood pressure data obtained in
routine clinical practice. Findings from CAMBO and
other recent similar studies indicate that a manual
office blood pressure of 140/90 mm Hg taken as part
of a research study is likely to be equivalent to a reading
of at least 150/95 mm Hg when recorded in routine
clinical practice,19 31 raising concerns about the exter-
nal validity of manual office blood pressure readings
taken under research conditions.
Automated office blood pressure readings are an
alternative tomanual readings, as they are less affected
by the setting in which they are taken (providing the
patient is alone),17 are similar to themean awake ambu-
latory blood pressure, and are less likely to provoke a
white coat effect.2 Automated office blood pressure has
also become available at a crucial time in the 100 years
of office bloodpressuremeasurement.Advocates of 24
hour ambulatory blood pressure monitoring have
recommended introducing ambulatory monitoring
into primary care to overcome the problems associated
with current manual office blood pressure
measurement.33 34 Recentmonographs from theAmer-
ican Heart Association and the European Society of
Hypertension have also recommended thewidespread
use of home blood pressuremonitoring.1 33 The Amer-
icanHeart Association report stated that “every hyper-
tensive patient should purchase a home BP recording
device.”1 Although few hypertension experts have
gone as far as recommending the complete abandon-
ment of office blood pressure measurement, conven-
tional manual office blood pressure readings are
clearly widely viewed as providing suboptimal mea-
sures of an individual patient’s blood pressure status.
Automated office blood pressure measurement pro-
vides an opportunity to continue recording blood pres-
sure in the primary care setting, although it is not a
replacement for home blood pressure or 24 hour
ambulatory blood pressure monitoring. Identification
of a close relation between readings taken with auto-
mated office blood pressuremeasurement and 24 hour
ambulatory blood pressure monitoring suggests that
future clinical outcome studies will confirm automated
office blood pressure readings as being a better predic-
tor of future cardiovascular events than are manual
office blood pressure readings.
The initial findings from the CAMBO trial in
patients with systolic hypertension and no serious
comorbidities highlight the importance of recording
blood pressure in the office with a fully automated
device that takes multiple readings with the patient
resting alone in the examining room. Further studies
in other hypertensive populations are needed before
automated office blood pressure can be recommended
as a replacement for conventional manual blood pres-
sure measurement.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Increasing concern about the accuracy and reliability ofmanual blood pressuremeasurement
in clinical practice has led to greater reliance on home and ambulatory blood pressure
recordings using automated devices
The use of automated devices to measure blood pressure in the office setting with multiple
readings taken while the patient rests alone in a quiet room overcomes many of the
shortcomings of the manual technique
WHAT THE STUDY ADDS
Automated office blood pressure can be used in primary care practice to obtain valid
readings without provoking the white coat response often seen with manual blood pressure
measurement
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